Clinical Trial

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer

Study acronym: ESOCARE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 19, 2018 (before its estimated December 31, 2021 completion). Its status may not reflect the trial's current state.
Summary
Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.
Trial Details
NCT Number NCT03712774
Lead Sponsor Ludwig-Maximilians - University of Munich
Conditions Quality of Life, Chemoradiation, Esophageal Cancer
Enrollment 60 participants
Start Date 2018-10-12
Primary Completion 2021-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2018-10-19